Aurisin A Complexed with 2,6-Di-O-methyl-β-cyclodextrin Enhances Aqueous Solubility, Thermal Stability, and Antiproliferative Activity against Lung Cancer Cells

被引:6
|
作者
Charoenwongpaiboon, Thanapon [1 ]
Oo, Amy [2 ]
Nasoontorn, Sutita [3 ]
Rungrotmongkol, Thanyada [2 ,4 ]
Kanokmedhakul, Somdej [5 ,6 ]
Mahalapbutr, Panupong [3 ]
机构
[1] Silpakorn Univ, Fac Sci, Dept Chem, Bangkok 73000, Nakhon Pathom, Thailand
[2] Chulalongkorn Univ, Ctr Excellence Struct & Computat Biol, Dept Biochem, Bangkok 10330, Thailand
[3] Khon Kaen Univ, Fac Med, Ctr Translat Med, Dept Biochem, Khon Kaen 40002, Thailand
[4] Chulalongkorn Univ, Grad Sch, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand
[5] Khon Kaen Univ, Fac Sci, Dept Chem, Nat Prod Res Unit, Khon Kaen 40002, Thailand
[6] Khon Kaen Univ, Fac Sci, Ctr Innovat Chem, Khon Kaen 40002, Thailand
关键词
Aurisin A; beta-cyclodextrins; inclusion complex; lung cancer; CYCLODEXTRIN INCLUSION COMPLEX; BETA-CYCLODEXTRIN; MOLECULAR-DYNAMICS; PHYSICOCHEMICAL PROPERTIES; IN-VITRO; ANTIOXIDANT; ENCAPSULATION; IMPROVEMENT; SYSTEM; ENERGY;
D O I
10.3390/ijms23179776
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aurisin A (AA), an aristolane dimer sesquiterpene isolated from the luminescent mushroom Neonothopanus nambi, exhibits various biological and pharmacological effects. However, its poor solubility limits its use for further medicinal applications. This study aimed to improve the water solubility of AA via complexation with beta-cyclodextrin (beta CD) and its derivatives (2,6-di-O-methyl-beta CD (DM beta CD) and 2-hydroxypropyl-beta CD (HP beta CD). A phase solubility analysis demonstrated that the solubility of AA linearly enhanced with increasing concentrations of beta CDs (ranked in the order of AA/DM beta CD > AA/HP beta CD > AA/beta CD). Notably, beta CDs, especially DM beta CD, increased the thermal stability of the inclusion complexes. The thermodynamic study indicated that the complexation between AA and beta CD(s) was a spontaneous endothermic reaction, and AA/DM beta CD possesses the highest binding strength. The complex formation between AA and DM beta CD was confirmed by means of FT-IR, DSC, and SEM. Molecular dynamics simulations revealed that the stability and compactness of the AA/DM beta CD complex were higher than those of the DM beta CD alone. The encapsulation of AA led to increased intramolecular H-bond formations on the wider rim of DM beta CD, enhancing the complex stability. The antiproliferative activity of AA against A549 and H1975 lung cancer cells was significantly improved by complexation with DM beta CD. Altogether, the satisfactory water solubility, high thermal stability, and enhanced antitumor potential of the AA/DM beta CD inclusion complex would be useful for its application as healthcare products or herbal medicines.
引用
收藏
页数:16
相关论文
共 4 条
  • [1] Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-β-cyclodextrin solution
    Iohara, Daisuke
    Hirayama, Fumitoshi
    Ishiguro, Takako
    Arima, Hidetoshi
    Uekama, Kaneto
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 354 (1-2) : 70 - 76
  • [2] Development of cannabidiol full-spectrum oil/2,6-di-O-methyl-β-cyclodextrin inclusion complex with enhanced water solubility, bioactivity, and thermal stability
    Li, Hang
    Zhao, Qing-Sheng
    Chang, Sen-Lin
    Chang, Tan-Ran
    Tan, Ming-Hui
    Zhao, Bing
    JOURNAL OF MOLECULAR LIQUIDS, 2022, 347
  • [3] Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-β-cyclodextrin, not 2,6-di-O-methyl-α-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells
    Motoyama, Keiichi
    Kameyama, Kazuhisa
    Onodera, Risako
    Araki, Norie
    Hirayama, Fumitoshi
    Uekama, Kaneto
    Arima, Hidetoshi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (03) : 249 - 261
  • [4] THE EFFECT OF HEPTAKIS (2,6-DI-O-METHYL)-GAMMA-CYCLODEXTRIN ON MITOMYCIN-C STABILITY IN AQUEOUS-SOLUTION
    SUENAGA, A
    BEKERS, O
    BEIJNEN, JH
    UNDERBERG, WJM
    TANIMOTO, T
    KOIZUMI, K
    OTAGIRI, M
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 59 (02) : 121 - 130